IRIS-Insulin Resistance Intervention after Stroke Trial. A randomized placebo-controlled trial of pioglitazone compared with placebo for prevention of stroke and myocardial infarction after ischemic stroke and transient ischemic attack

Project: Federal Funding Agencies

Project Details

StatusFinished
Effective start/end date7/1/06 → 8/31/15

Funding

  • Yale University